Why Did Players Hold Cautious Sentiment in the Chinese Acrylic Emulsion Market

In 2017, China exported 28,849.08mt of Chloroacetic Acid, down 7.24% year on year. High prices boosted by the strict environmental protection supervision in China were the major reason for the declines in export. The average price of chloroacetic acid in 2017 was RMB 4,182/mt, increasing 47.88% year on year.

Turkey, Russia, Columbia, the U.S., and South Korea were the major importers of China’s chloroacetic acid. Influenced by the high prices of chloroacetic acid, the export to Russia and the U.S. in H2, 2017 slumped. If the Chloroacetic Acid prices remain above RMB 4,500/mt, the arbitrage window from China to Europe and America regions will close.

Based on the point of origin, Shandong Minji Chemical was the major exporter of chloroacetic acid. In Q4, 2017, the new 60kt/a capacity released. Moreover, the export prices were lower than other export prices. Shandong Minji Chemical mainly exported the goods to ease the inventory pressure.

Though Shandong Minji was the major exporter, the Qingdao Customs had stopped the export of chloroacetic acid in 2017. Nanjing and Shanghai will be the two major customs when exporting chloroacetic acid.
Looking for chemical products? Let suppliers reach out to you!
2026-06-29
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Recommend Reading
-
After Two Rounds of Price Cuts, the Coke Market Stabilizes in China
-
Insufficient Downstream Demand Puts Pressure on DMF Market
-
Cyclohexane Market Supply and Demand Balance, Prices Remain Stable
-
Methanol Market Partially Rises
-
Recent Weak Performance of Dichloromethane
-
The FDA Officially Blesses AI for Liver Drug Development
-
UBE Corporation Accelerates Chemical Business Shift Halts Key Operations by 2028
-
SABIC Shuts Down 865,000-Ton UK Ethylene Plant as Europe Faces Petrochemical Cuts
-
Smog Becomes a Sales Catalyst as Respiratory Drugs Surge in November
-
U.S. FDA Opens New Safety Review of RSV Treatments for Infants